LEMAITRE VASCULAR, INC. Selling and Marketing Expense
LEMAITRE VASCULAR, INC. (LMAT) reported Selling and Marketing Expense of $14.41 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-08-05
- LEMAITRE VASCULAR, INC. selling and marketing expense for the quarter ending 2026-06-30 was $14.41M, a 3.27% decline year-over-year.
- LEMAITRE VASCULAR, INC. selling and marketing expense for the quarter ending 2026-03-31 was $14.52M, a 2.13% increase year-over-year.
- LEMAITRE VASCULAR, INC. selling and marketing expense for the quarter ending 2025-12-31 was $13.43M, a 6.40% increase year-over-year.
- LEMAITRE VASCULAR, INC. selling and marketing expense for the quarter ending 2025-09-30 was $11.92M, a 4.21% increase year-over-year.
- LEMAITRE VASCULAR, INC. selling and marketing expense for fiscal 2025 was $54.46M, a 16.53% increase from fiscal 2024.
- LEMAITRE VASCULAR, INC. selling and marketing expense for fiscal 2024 was $46.74M, a 13.84% increase from fiscal 2023.
- LEMAITRE VASCULAR, INC. selling and marketing expense for fiscal 2023 was $41.05M, a 24.70% increase from fiscal 2022.
- LEMAITRE VASCULAR, INC. selling and marketing expense for fiscal 2022 was $32.92M, a 19.04% increase from fiscal 2021.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 6 month | Selling and Marketing Expense 9 month | Selling and Marketing Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $14.41M 10-Q · filed 2026-08-05 | $28.92M 10-Q · filed 2026-08-05 | $42.36M derived: sum of 3 quarters · filed 2026-08-05 | $54.28M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $14.52M 10-Q · filed 2026-05-06 | $27.95M derived: sum of 2 quarters · filed 2026-05-06 | $39.87M derived: sum of 3 quarters · filed 2026-05-06 | $54.77M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $13.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $25.36M derived: sum of 2 quarters · filed 2026-02-26 | $40.25M derived: sum of 3 quarters · filed 2026-08-05 | $54.46M 10-K · filed 2026-02-26 |
| 2025-09-30 | $11.92M 10-Q · filed 2025-11-07 | $26.82M derived: sum of 2 quarters · filed 2026-08-05 | $41.03M 10-Q · filed 2025-11-07 | $53.66M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $14.89M 10-Q · filed 2026-08-05 | $29.11M 10-Q · filed 2026-08-05 | $41.73M derived: sum of 3 quarters · filed 2026-08-05 | $53.17M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $14.21M 10-Q · filed 2026-05-06 | $26.84M derived: sum of 2 quarters · filed 2026-05-06 | $38.28M derived: sum of 3 quarters · filed 2026-05-06 | $49.26M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $12.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $24.07M derived: sum of 2 quarters · filed 2026-02-26 | $35.05M derived: sum of 3 quarters · filed 2026-02-26 | $46.74M 10-K · filed 2026-02-26 |
| 2024-09-30 | $11.44M 10-Q · filed 2025-11-07 | $22.43M derived: sum of 2 quarters · filed 2025-11-07 | $34.11M 10-Q · filed 2025-11-07 | $44.38M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $10.98M 10-Q · filed 2025-08-06 | $22.67M 10-Q · filed 2025-08-06 | $32.94M derived: sum of 3 quarters · filed 2026-02-26 | $42.61M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $11.69M 10-Q · filed 2025-05-08 | $21.95M derived: sum of 2 quarters · filed 2026-02-26 | $31.63M derived: sum of 3 quarters · filed 2026-02-26 | $41.84M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $10.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $19.94M derived: sum of 2 quarters · filed 2026-02-26 | $30.16M derived: sum of 3 quarters · filed 2026-02-26 | $41.05M 10-K · filed 2026-02-26 |
| 2023-09-30 | $9.67M 10-Q · filed 2024-11-08 | $19.89M derived: sum of 2 quarters · filed 2024-11-08 | $30.79M 10-Q · filed 2024-11-08 | $39.39M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $10.22M 10-Q · filed 2024-08-08 | $21.11M 10-Q · filed 2024-08-08 | $29.71M derived: sum of 3 quarters · filed 2025-02-28 | $37.94M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $10.90M 10-Q · filed 2024-05-10 | $19.50M derived: sum of 2 quarters · filed 2025-02-28 | $27.73M derived: sum of 3 quarters · filed 2025-02-28 | $35.97M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $8.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $16.83M derived: sum of 2 quarters · filed 2025-02-28 | $25.07M derived: sum of 3 quarters · filed 2025-02-28 | $32.92M 10-K · filed 2025-02-28 |
| 2022-09-30 | $8.23M 10-Q · filed 2023-11-07 | $16.47M derived: sum of 2 quarters · filed 2023-11-07 | $24.32M 10-Q · filed 2023-11-07 | $31.77M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $8.24M 10-Q · filed 2023-08-08 | $16.09M 10-Q · filed 2023-08-08 | $23.54M derived: sum of 3 quarters · filed 2024-02-29 | $30.48M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $7.85M 10-Q · filed 2023-05-09 | $15.29M derived: sum of 2 quarters · filed 2024-02-29 | $22.24M derived: sum of 3 quarters · filed 2024-02-29 | $29.04M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $7.45M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $14.39M derived: sum of 2 quarters · filed 2024-02-29 | $21.19M derived: sum of 3 quarters · filed 2024-02-29 | $27.66M 10-K · filed 2024-02-29 |
| 2021-09-30 | $6.94M 10-Q · filed 2022-11-08 | $13.74M derived: sum of 2 quarters · filed 2022-11-08 | $20.21M 10-Q · filed 2022-11-08 | $26.12M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $6.80M 10-Q · filed 2022-08-05 | $13.27M 10-Q · filed 2022-08-05 | $19.18M derived: sum of 3 quarters · filed 2023-03-01 | $24.34M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $6.47M 10-Q · filed 2022-05-10 | $12.38M derived: sum of 2 quarters · filed 2023-03-01 | $17.54M derived: sum of 3 quarters · filed 2023-03-01 | $22.22M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $5.91M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $11.07M derived: sum of 2 quarters · filed 2023-03-01 | $15.76M derived: sum of 3 quarters · filed 2023-03-01 | $23.70M 10-K · filed 2023-03-01 |
| 2020-09-30 | $5.16M 10-Q · filed 2021-11-04 | $9.84M derived: sum of 2 quarters · filed 2021-11-04 | $17.79M 10-Q · filed 2021-11-04 | $25.24M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $4.69M 10-Q · filed 2021-08-05 | $12.63M 10-Q · filed 2021-08-05 | $20.08M derived: sum of 3 quarters · filed 2022-02-28 | $27.51M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $7.95M 10-Q · filed 2021-05-10 | $15.40M derived: sum of 2 quarters · filed 2022-02-28 | $22.83M derived: sum of 3 quarters · filed 2022-02-28 | $30.44M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $7.45M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $14.88M derived: sum of 2 quarters · filed 2022-02-28 | $22.49M derived: sum of 3 quarters · filed 2022-02-28 | $30.34M 10-K · filed 2022-02-28 |
| 2019-09-30 | $7.43M 10-Q · filed 2020-11-06 | $15.04M derived: sum of 2 quarters · filed 2020-11-06 | $22.89M 10-Q · filed 2020-11-06 | $29.70M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-06-30 | $7.61M 10-Q · filed 2020-08-06 | $15.46M 10-Q · filed 2020-08-06 | $22.27M derived: sum of 3 quarters · filed 2021-03-12 | $28.89M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-03-31 | $7.84M 10-Q · filed 2020-05-08 | $14.66M derived: sum of 2 quarters · filed 2021-03-12 | $21.28M derived: sum of 3 quarters · filed 2021-03-12 | $28.07M derived: sum of 4 quarters · filed 2021-03-12 |
| 2018-12-31 | $6.81M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $13.44M derived: sum of 2 quarters · filed 2021-03-12 | $20.23M derived: sum of 3 quarters · filed 2021-03-12 | $27.32M 10-K · filed 2021-03-12 |
| 2018-09-30 | $6.62M 10-Q · filed 2019-11-08 | $13.41M derived: sum of 2 quarters · filed 2019-11-08 | $20.50M 10-Q · filed 2019-11-08 | $26.70M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | $6.79M 10-Q · filed 2018-08-06 | $13.88M 10-Q · filed 2019-08-06 | $20.08M derived: sum of 3 quarters · filed 2020-03-12 | $26.28M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | $7.09M 10-Q · filed 2019-05-06 | $13.28M derived: sum of 2 quarters · filed 2020-03-12 | $19.48M derived: sum of 3 quarters · filed 2020-03-12 | $26.08M derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | $6.19M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $12.39M derived: sum of 2 quarters · filed 2020-03-12 | $18.99M derived: sum of 3 quarters · filed 2020-03-12 | $25.95M 10-K · filed 2020-03-12 |
| 2017-09-30 | $6.20M 10-Q · filed 2018-11-02 | $12.80M derived: sum of 2 quarters · filed 2018-11-02 | $19.75M 10-Q · filed 2018-11-02 | $26.51M derived: sum of 4 quarters · filed 2019-03-11 |
| 2017-06-30 | $6.60M 10-Q · filed 2018-08-06 | $13.55M 10-Q · filed 2018-08-06 | $20.30M derived: sum of 3 quarters · filed 2019-03-11 | $26.85M derived: sum of 4 quarters · filed 2019-03-11 |
| 2017-03-31 | $6.95M 10-Q · filed 2018-05-04 | $13.71M derived: sum of 2 quarters · filed 2019-03-11 | $20.25M derived: sum of 3 quarters · filed 2019-03-11 | $26.79M derived: sum of 4 quarters · filed 2019-03-11 |
| 2016-12-31 | $6.75M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11 | $13.29M derived: sum of 2 quarters · filed 2019-03-11 | $19.83M derived: sum of 3 quarters · filed 2019-03-11 | $26.11M 10-K · filed 2019-03-11 |
| 2016-09-30 | $6.54M 10-Q · filed 2017-11-03 | $13.08M derived: sum of 2 quarters · filed 2017-11-03 | $19.35M 10-Q · filed 2017-11-03 | $25.27M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-06-30 | $6.54M 10-Q · filed 2017-08-03 | $12.81M 10-Q · filed 2017-08-03 | $18.73M derived: sum of 3 quarters · filed 2018-03-09 | $24.21M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-03-31 | $6.27M 10-Q · filed 2017-05-04 | $12.19M derived: sum of 2 quarters · filed 2018-03-09 | $17.68M derived: sum of 3 quarters · filed 2018-03-09 | $23.20M derived: sum of 4 quarters · filed 2018-03-09 |
| 2015-12-31 | $5.91M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $11.40M derived: sum of 2 quarters · filed 2018-03-09 | $16.92M derived: sum of 3 quarters · filed 2018-03-09 | $22.78M 10-K · filed 2018-03-09 |
| 2015-09-30 | $5.49M 10-Q · filed 2016-11-04 | $11.01M derived: sum of 2 quarters · filed 2016-11-04 | $16.87M 10-Q · filed 2016-11-04 | $22.10M derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-06-30 | $5.52M 10-Q · filed 2016-08-05 | $11.38M 10-Q · filed 2016-08-05 | $16.61M derived: sum of 3 quarters · filed 2017-03-09 | $21.70M derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-03-31 | $5.86M 10-Q · filed 2016-05-06 | $11.09M derived: sum of 2 quarters · filed 2017-03-09 | $16.18M derived: sum of 3 quarters · filed 2017-03-09 | $21.72M derived: sum of 4 quarters · filed 2017-03-09 |
| 2014-12-31 | $5.23M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $10.32M derived: sum of 2 quarters · filed 2017-03-09 | $15.86M derived: sum of 3 quarters · filed 2017-03-09 | $22.09M 10-K · filed 2017-03-09 |
| 2014-09-30 | $5.09M 10-Q · filed 2015-11-06 | $10.63M derived: sum of 2 quarters · filed 2015-11-06 | $16.86M 10-Q · filed 2015-11-06 | $22.72M derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-06-30 | $5.54M 10-Q · filed 2015-08-06 | $11.77M 10-Q · filed 2015-08-06 | $17.63M derived: sum of 3 quarters · filed 2016-03-10 | $22.84M derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-03-31 | $6.23M 10-Q · filed 2015-05-07 | $12.09M derived: sum of 2 quarters · filed 2016-03-10 | $17.30M derived: sum of 3 quarters · filed 2016-03-10 | $22.60M derived: sum of 4 quarters · filed 2016-03-10 |
| 2013-12-31 | $5.87M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $11.07M derived: sum of 2 quarters · filed 2016-03-10 | $16.38M derived: sum of 3 quarters · filed 2016-03-10 | $22.14M 10-K · filed 2016-03-10 |
| 2013-09-30 | $5.21M 10-Q · filed 2014-11-06 | $10.51M derived: sum of 2 quarters · filed 2014-11-06 | $16.28M 10-Q · filed 2014-11-06 | $21.78M derived: sum of 4 quarters · filed 2015-03-18 |
| 2013-06-30 | $5.30M 10-Q · filed 2014-08-07 | $11.07M 10-Q · filed 2014-08-07 | $16.57M derived: sum of 3 quarters · filed 2015-03-18 | $21.48M derived: sum of 4 quarters · filed 2015-03-18 |
| 2013-03-31 | $5.77M 10-Q · filed 2014-05-08 | $11.27M derived: sum of 2 quarters · filed 2015-03-18 | $16.18M derived: sum of 3 quarters · filed 2015-03-18 | $21.37M derived: sum of 4 quarters · filed 2015-03-18 |
| 2012-12-31 | $5.50M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-18 | $10.41M derived: sum of 2 quarters · filed 2015-03-18 | $15.60M derived: sum of 3 quarters · filed 2015-03-18 | $20.81M 10-K · filed 2015-03-18 |
| 2012-09-30 | $4.91M 10-Q · filed 2013-11-07 | $10.10M derived: sum of 2 quarters · filed 2013-11-07 | $15.31M 10-Q · filed 2013-11-07 | $20.04M derived: sum of 4 quarters · filed 2014-03-21 |
| 2012-06-30 | $5.19M 10-Q · filed 2013-08-09 | $10.40M 10-Q · filed 2013-08-09 | $15.13M derived: sum of 3 quarters · filed 2014-03-21 | $19.89M derived: sum of 4 quarters · filed 2014-03-21 |
| 2012-03-31 | $5.21M 10-Q · filed 2013-05-08 | $9.94M derived: sum of 2 quarters · filed 2014-03-21 | $14.70M derived: sum of 3 quarters · filed 2014-03-21 | $19.61M derived: sum of 4 quarters · filed 2014-03-21 |
| 2011-12-31 | $4.73M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | $9.49M derived: sum of 2 quarters · filed 2014-03-21 | $14.40M derived: sum of 3 quarters · filed 2014-03-21 | $19.38M 10-K · filed 2014-03-21 |
| 2011-09-30 | $4.76M 10-Q · filed 2012-11-09 | $9.67M derived: sum of 2 quarters · filed 2012-11-09 | $14.65M 10-Q · filed 2012-11-09 | $19.72M derived: sum of 4 quarters · filed 2013-03-27 |
| 2011-06-30 | $4.92M 10-Q · filed 2012-08-10 | $9.89M 10-Q · filed 2012-08-10 | $14.96M derived: sum of 3 quarters · filed 2013-03-27 | $19.66M derived: sum of 4 quarters · filed 2013-03-27 |
| 2011-03-31 | $4.97M 10-Q · filed 2012-05-03 | $10.04M derived: sum of 2 quarters · filed 2013-03-27 | $14.74M derived: sum of 3 quarters · filed 2013-03-27 | $19.49M derived: sum of 4 quarters · filed 2013-03-27 |
| 2010-12-31 | $5.07M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-27 | $9.77M derived: sum of 2 quarters · filed 2013-03-27 | $14.52M derived: sum of 3 quarters · filed 2013-03-27 | $19.41M 10-K · filed 2013-03-27 |
| 2010-09-30 | $4.70M 10-Q · filed 2011-11-14 | $9.45M derived: sum of 2 quarters · filed 2011-11-14 | $14.34M 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $4.75M 10-Q · filed 2011-08-12 | $9.64M 10-Q · filed 2011-08-12 | ||
| 2009-12-31 | $17.71M 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |